KOSDAQElectronic Components179900

Uti

₩2,315▲ 5.47%2026-10-02 close
Market Cap
₩49.9B
Turnover
₩400M
Volume
190,000 shares
Shares out.
21.6M
PER
—
PBR
0.6×
EPS
-₩949
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩0 per share · Prices as of the 2026-10-02 close

01

Report overview

UTI Inc: Betting on Foldable Glass Amid Ongoing Losses

UTI Inc has posted net losses for four consecutive years, and its foldable-phone UTG/UFG glass and semiconductor glass-substrate businesses, developed with Corning, have become the key variable for a potential earnings turnaround.

  1. 1

    Revenue recovered to roughly KRW 20.0 billion in 2025, but the operating loss widened to about KRW 48.3 billion, marking a fourth straight year of losses.

  2. 2

    Net income attributable to owners turned positive at about KRW 13.9 billion in 2026Q2, even as the operating loss widened to roughly KRW 15.9 billion in the same quarter, suggesting the swing likely stemmed from non-operating items rather than core business improvement.

  3. 3

    Corning has become UTI's second-largest shareholder with a 9.28% stake through convertible preferred stock conversion, and the UTG/UFG glass technology co-developed with Corning is central to the company's new growth push.

  4. 4

    Mass production of UTG for a North American customer ('Company A') began on July 27, 2026, but order volume was cut from an initially discussed 3 million units to 1.2 million, which the company attributed to wastewater-treatment regulatory limits at its Vietnam plant.

  5. 5

    The debt ratio rose again to 227.4% in 2025, and operating cash flow has been negative for three consecutive years (2023–2025), reflecting continued financial strain.

02

Business structure

UTI Inc is a precision glass processing company that researches, develops, manufactures, and sells smartphone camera windows, sensor glass, and integrated modules.

The business runs on two main axes: an optical cover-glass segment centered on camera-lens protection covers for smartphones and tablets and transparent-electrode glass for fingerprint recognition, and a module/parts segment covering sensor-haptic modules, IoT composite sensors, and automotive touchscreen parts (G2 TSP).

Production takes place at a domestic plant and at Vietnamese subsidiaries, with the plant in Thai Nguyen industrial park producing an average of 22 million camera protection glass units and 7.8 million speaker protection films per month.

As new growth drivers, the company is developing ultra-thin tempered glass (UTG) for foldable smartphones, ultra-flexible glass (UFG) co-developed with Corning, and glass substrates for semiconductor packaging.

Corning became UTI's second-largest shareholder with a 9.28% stake through the conversion of convertible preferred stock, underpinning the stability of the technology partnership.

The customer base includes participation in the UTG supply chain for Samsung Electronics' foldable phones (Galaxy Z Flip) and UTG collaboration with a North American technology customer ('Company A'), and UTI is also cited as a potential second-source vendor in Apple's foldable iPhone supply chain.

However, China's Lens Technology is considered the likely primary vendor for Apple's foldable UTG, with UTI competing against domestic peers such as Dowoo Insys and BOE-Lens-related suppliers for second-source status.

Structurally, the revenue base is concentrated among a limited number of smartphone customers and models, which can amplify order volatility.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q2₩5.5B-₩9.6B−174.0%
2025Q3₩4.6B-₩13.3B−288.0%
2025Q4₩5.1B-₩15.7B−306.9%
2026Q1₩4.8B-₩13.2B−276.1%
2026Q2₩5.5B-₩15.9B−289.2%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩36.4B-₩4.6B-₩12B−12.7%−25.4%143.7%
2023₩19.4B-₩19.7B-₩29.5B−101.9%−171.9%485.7%
2024₩18.6B-₩32.2B-₩22.7B−173.7%−30.5%115.5%
2025₩20B-₩48.3B-₩37.4B−241.9%−57.1%227.4%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-08-23

04

Earnings analysis

UTI Inc has recorded consolidated operating losses and net losses for four consecutive years from 2022 through 2025. Revenue fell sharply from about KRW 36.4 billion in 2022 to KRW 19.4 billion in 2023, then edged up modestly to KRW 18.6 billion in 2024 and KRW 20.0 billion in 2025.

Even so, the operating loss kept widening through the revenue recovery, growing from about KRW 4.6 billion in 2022 to KRW 19.7 billion in 2023, KRW 32.2 billion in 2024, and KRW 48.3 billion in 2025, while the operating margin deteriorated from -12.7% in 2022 to -241.9% in 2025.

Net loss attributable to owners fluctuated between roughly KRW 12.0 billion (2022), KRW 29.5 billion (2023), KRW 22.7 billion (2024), and KRW 37.4 billion (2025).

On a quarterly basis, operating losses exceeded KRW 10 billion in every quarter from 2025Q3 (-KRW 13.3bn) through 2025Q4 (-KRW 15.7bn), 2026Q1 (-KRW 13.2bn), and 2026Q2 (-KRW 15.9bn), keeping the loss trend intact.

However, net income attributable to owners showed much larger quarter-to-quarter swings: the net loss narrowed sharply to about KRW 1.0 billion in 2025Q4 from KRW 15.9 billion in the prior quarter, and then flipped to a net profit of roughly KRW 13.9 billion in 2026Q2 even as the operating loss widened in the same quarter.

This large gap between operating and net results points to the likely influence of non-operating items, making it difficult to conclude that core profitability has genuinely recovered.

On the cash-flow side, operating cash flow swung from about +KRW 3.2 billion in 2022 to -KRW 8.4 billion in 2023, -KRW 31.3 billion in 2024, and -KRW 35.2 billion in 2025, with the cash burn accelerating.

The balance sheet also weakened, as the debt ratio spiked to 485.7% in 2023, eased to 115.5% in 2024, and rose again to 227.4% in 2025.

05

Industry analysis

The foldable smartphone market is emerging as a new premium growth axis as conventional bar-type smartphones mature, with the industry projecting global shipment growth of more than 20% annually.

Apple is building out its UTG (ultra-thin tempered glass) supply chain with a target of launching a foldable iPhone in 2026, and this material is considered a key component determining the finished quality of foldable devices.

However, China's Lens Technology is seen as the likely primary vendor for Apple's foldable UTG, and reports indicate that for Apple's first foldable product this year, Lens Technology is supplying the UTG for both the top and bottom panels as the main vendor.

Samsung Electronics' foldable phones split their supply chains by model: UTG for the clamshell-type Galaxy Z Flip runs through the Samsung Electronics/Corning supply chain, while UTG for the book-type Galaxy Z Fold runs through the Samsung Display/Schott/Dowoo Insys supply chain; UTI is included in the Z Flip supply chain but related revenue has been limited until recently.

Competitor Dowoo Insys has already broken ground on a second Vietnam plant, making preemptive investments to prepare for new customers and expanded volume, intensifying competition in the back-end processing market.

Glass substrates for semiconductor packaging are also drawing attention as a future growth area from multiple companies including Corning, aligning with UTI's diversification direction.

That said, the broader smartphone components industry remains locked into a low-margin structure amid maturing demand and intensifying competition, making the pace of transition into new foldable-glass and glass-substrate businesses the key variable for future results.

06

Outlook

In a March 2026 interview, CEO Park Deok-young stated that new UTG products for a new customer are a high-margin business expected to deliver operating margins above 30%, and that as utilization rises after mass production begins, the Vietnam subsidiary is expected to turn profitable not only in the second half of 2026 but on a full-year basis as well.

UTI is reported to have begun mass production of UTG for a North American customer's ('Company A') foldable phone starting July 27, 2026.

However, the initially discussed order volume was cut from 3 million units to 1.2 million, which the company attributed to production capacity constraints and environmental regulatory issues at its Vietnam plant.

The company built two plants in Vietnam but only one is currently operating due to wastewater-treatment regulations, and it has stated a plan to raise daily output from about 26,000 units to 60,000 units and expand orders once the regulatory issue is resolved.

On the financing side, UTI raised roughly KRW 132.0 billion through six rounds of convertible bonds (CBs) between May 2024 and May 2026, and when investors exercised put options on a portion of the first-round CB (worth about KRW 54.2 billion) that matured in May 2026, the company responded with a sixth-round CB (KRW 10.0 billion) and retained earnings (KRW 7.0 billion).

Loans totaling about KRW 38.4 billion for Vietnam facility investment have maturities being extended in three-year increments beyond 2029, limiting near-term repayment pressure, though the burden of CB rollovers persists.

Regarding potential inclusion in Apple's foldable supply chain, industry reports in the first half of 2026 raised the possibility of UTI being a second-source vendor candidate or even a primary partner, but confirmation remains difficult due to non-disclosure agreements.

07

Valuation

PER
—
PBR
0.6×
ROE
-30.8%
EPS
-₩949
BPS
₩3,671
Dividend per share
₩0

UTI has posted net losses for four consecutive years, so a conventional price-to-earnings (PER) figure is not meaningful for the stock.

Looking at the relationship between the share price and net assets, the stock has continued to trade at a level below its book value per share, which could be interpreted as the market not yet fully pricing in the potential of the new business lines into asset value.

Dividends have not been paid in recent years amid persistent net losses, and dividend-related metrics remain below the sector average.

Given its small market capitalization, the stock's structure makes it sensitive to single issues such as order news, currency moves, or convertible-bond developments, which can amplify price volatility.

Overall, the current valuation appears to reflect two opposing forces at once: market expectations around the potential realization of the foldable UTG and glass-substrate businesses, and the ongoing burden of core-business losses and a stretched balance sheet.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-08-23

08

Bull factors

Expectations for the UTG/UFG New Business Transition

Building on UTG/UFG technology co-developed with Corning, UTI participates in the Samsung Galaxy Z Flip supply chain, and mass production of UTG for a North American customer ('Company A') began in July 2026.

The CEO has stated that the new UTG products carry operating margins above 30%, far higher than the existing business. With the foldable market projected to grow more than 20% annually, rising utilization has room to translate into expanded revenue.

Corning's Presence as a Strategic Shareholder

Corning is UTI's second-largest shareholder with a 9.28% stake gained through convertible preferred stock conversion, which is a favorable factor for technology cooperation and credibility.

Reports that Corning is considering Korea as a production base for semiconductor glass substrates leave the door open for further collaboration.

Dual Production Base in Vietnam

UTI has established two Vietnamese subsidiaries and plants, UTI VINA and UTI VINA VINH PHUC, investing more than $100 million in total. Once wastewater-treatment regulations are resolved, the company plans to more than double its daily output, leaving room for supply capacity expansion.

09

Bear factors

Four Straight Years of Losses, Widening in Scale

While revenue has stayed around KRW 20.0 billion, the operating loss grew every year from about KRW 4.6 billion in 2022 to KRW 48.3 billion in 2025. That losses widened even as revenue recovered from 2024 to 2025 indicates a structurally heavy burden of fixed costs and R&D spending.

Cash Burn and Balance-Sheet Strain

Operating cash flow has been negative for three straight years since 2023, widening to about -KRW 35.2 billion in 2025. The debt ratio rose again to 227.4% in 2025, and the company has repeatedly relied on CB rollovers and responses to put-option exercises, reflecting high dependence on external financing.

Volume and Timeline Uncertainty

UTG mass-production volume for the North American customer was cut from an initially discussed 3 million units to 1.2 million, and the wastewater-treatment regulation cited as the cause at the Vietnam plant has not yet been resolved.

China's Lens Technology is seen as the likely primary vendor for Apple's foldable UTG, leaving UTI's role at the level of a second-source vendor candidate.

10

Risk factors

Customer Concentration Risk

Because revenue is concentrated among a small number of smartphone customers and models, results can swing significantly with changes in a single customer's orders or supply-chain shifts.

Relationships with major customers such as Apple and Samsung are also subject to non-disclosure agreements, limiting publicly available information and making it difficult for investors to independently verify progress.

Financial and Liquidity Risk

The company has relied on repeated convertible-bond issuance, rollovers, and loan maturity extensions for financing, with the debt ratio reaching 227.4% in 2025. If put-option exercises on CBs become concentrated in the future, additional fundraising may be required.

Environmental Regulation and Ramp-Up Delay Risk

UTI's new Vietnam plant faces limited operation due to wastewater-treatment regulations, and the timing and manner of any resolution could alter the mass-production ramp-up schedule. Technical variables such as UTG yield stabilization and quality validation also remain outstanding.

11

What to watch next

  1. Mid-November 2026

    UTI's 2026Q3 results are due to be disclosed — a point to check whether the operating loss narrows and whether the 2026Q2 net profit swing proves one-off or continues.

  2. During 2026Q4

    Watch for any expansion in UTG production volume for the North American customer ('Company A') and additional reports or disclosures on UTI's status (primary/secondary vendor) in Apple's foldable supply chain.

  3. Early 2027

    Check whether the wastewater-treatment regulatory issue at the Vinh Phuc, Vietnam plant is resolved and how the plan to raise daily output to 60,000 units is progressing.

  4. Around March 2027

    UTI's FY2026 annual business report is due to be filed — a point to verify whether management's stated goal of a full-year 2026 profit turnaround was actually achieved.

12

Overall view

UTI Inc has recorded operating and net losses for four consecutive years from 2022 to 2025, reflecting structural profitability pressure amid a maturing smartphone components industry.

Revenue recovered modestly in 2025, yet the operating loss widened further, and the swing to a net profit in 2026Q2 — given the wide gap versus the operating result — is likely attributable to one-off, non-operating factors rather than a genuine turnaround.

The company's new growth pillars — UTG, UFG, and glass-substrate businesses — are taking shape through cooperation with Corning and participation in Samsung's and a North American customer's supply chains, but execution risk persists, as seen in the volume cut tied to environmental regulations at its Vietnam plant.

On the financial side, the debt ratio has risen again and operating cash flow has been negative for three straight years, keeping the company reliant on external financing.

Whether UTI is included in Apple's foldable supply chain remains difficult to verify publicly due to non-disclosure agreements, and with China's Lens Technology seen as the likely primary vendor, UTI's role appears limited to that of a second-source candidate for now.

The key variables for future earnings appear to be the pace at which new-business revenue materializes and the timing of a resolution to Vietnam production capacity constraints.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. m.thinkpool.com
  2. investing.com
  3. bullstory.io
  4. investing.com
  5. comp.fnguide.com
  6. antwinner.com
  7. littlebproject.com
  8. press9.kr
  9. m.finance.daum.net
  10. markets.hankyung.com
  11. kr.investing.com
  12. kind.krx.co.kr
  13. alphasquare.co.kr
  14. globenewswire.com
  15. kind.krx.co.kr
  16. aol.com
  17. equity.co.kr
  18. marketbeat.com

Report written 2026-09-05 · Data as of 2026-09-04

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.